Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer
Clinical trial NCT01069796 · TERMINATED
Trial details
- NCT number
- NCT01069796
- Sponsor
- ARCAGY/ GINECO GROUP
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2012-03-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.